The importance of resistance to direct antiviral drugs in HCV infection in clinical practice von Sarrazin, Christoph

Volltext

Antiviral therapy of hepatitis C in 2014: Do we need resistance testing? von Schneider, Maximilian David, Sarrazin, Christoph

Volltext

Treatment failure with DAA therapy: Importance of resistance von Sarrazin, Christoph

Volltext

Treatment predictors of a sustained virologic response in hepatitis B and C von Kau, Annika, Vermehren, Johannes, Sarrazin, Christoph

Volltext

Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis von Friedrich–Rust, Mireen, Ong, Mei–Fang, Martens, Swantje, Sarrazin, Christoph, Bojunga, Joerg, Zeuzem, Stefan, Herrmann, Eva

Volltext

The role of resistance in HCV treatment von Vermehren, Johannes, MD, Sarrazin, Christoph, MD

Volltext

Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients von Dietz, Julia, Susser, Simone, Berkowski, Caterina, Perner, Dany, Zeuzem, Stefan, Sarrazin, Christoph

Volltext

Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients von Susser, Simone, Welsch, Christoph, Wang, Yalan, Zettler, Markus, Domingues, Francisco S., Karey, Ursula, Hughes, Eric, Ralston, Robert, Tong, Xiao, Herrmann, Eva, Zeuzem, Stefan, Sarrazin, Christoph

Volltext

Viral Determinants of Resistance to Treatment in Patients with Hepatitis C von WOHNSLAND, Anette, HOFMANN, Wolf Peter, SARRAZIN, Christoph

Volltext

Reply to: “Unlocking hope: HCV re-treatment strategy for patients with active hepatocellular carcinoma” von Graf, Christiana, Sarrazin, Christoph, Dietz, Julia

Volltext

Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis von Hildebrand, Tatiana, Pannicke, Nadine, Dechene, Alexander, Gotthardt, Daniel N., Kirchner, Gabriele, Reiter, Florian P., Sterneck, Martina, Herzer, Kerstin, Lenzen, Henrike, Rupp, Christian, Barg‐Hock, Hannelore, Leuw, Philipp, Teufel, Andreas, Zimmer, Vincent, Lammert, Frank, Sarrazin, Christoph, Spengler, Ulrich, Rust, Christian, Manns, Michael P., Strassburg, Christian P., Schramm, Christoph, Weismüller, Tobias J.

Volltext

Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients von Sarrazin, Christoph, Susser, Simone, Doehring, Alexandra, Lange, Christian Markus, Müller, Tobias, Schlecker, Christina, Herrmann, Eva, Lötsch, Jörn, Berg, Thomas

Volltext

Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens von Maasoumy, Benjamin, Vermehren, Johannes, Welker, Martin-Walter, Bremer, Birgit, Perner, Dany, Höner zu Siederdissen, Christoph, Deterding, Katja, Lehmann, Patrick, Cloherty, Gavin, Reinhardt, Birgit, Pawlotsky, Jean-Michel, Manns, Michael P, Zeuzem, Stefan, Cornberg, Markus, Wedemeyer, Heiner, Sarrazin, Christoph

Volltext

Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region von Sarrazin, Christoph, Lathouwers, Erkki, Peeters, Monika, Daems, Bjorn, Buelens, Annemie, Witek, James, Wyckmans, Yves, Fevery, Bart, Verbinnen, Thierry, Ghys, Anne, Schlag, Michael, Baldini, Alessandra, De Meyer, Sandra, Lenz, Oliver

Volltext

Divergent preS Sequences in Virion-Associated Hepatitis B Virus Genomes and Subviral HBV Surface Antigen Particles From HBV e Antigen-Negative Patients von Peiffer, Kai-Henrik, Kuhnhenn, Lisa, Jiang, Bingfu, Mondorf, Antonia, Vermehren, Johannes, Knop, Viola, Susser, Simone, Walter, Dirk, Dietz, Julia, Carra, Gert, Finkelmeier, Fabian, Zeuzem, Stefan, Sarrazin, Christoph, Hildt, Eberhard

Volltext

Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection von Sarrazin, Christoph, Zeuzem, Stefan

Volltext

Telaprevir and pegylated interferon–alpha‐2a inhibit wild‐type and resistant genotype 1 hepatitis C virus replication in patients von Kieffer, Tara L., Sarrazin, Christoph, Miller, Janice S., Welker, Martin W., Forestier, Nicole, Reesink, Hendrik W., Kwong, Ann D., Zeuzem, Stefan

Volltext

Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants von Jensen, Sanne Brun, Fahnøe, Ulrik, Pham, Long V., Serre, Stéphanie Brigitte Nelly, Tang, Qi, Ghanem, Lubna, Pedersen, Martin Schou, Ramirez, Santseharay, Humes, Daryl, Pihl, Anne Finne, Filskov, Jonathan, Sølund, Christina Søhoel, Dietz, Julia, Fourati, Slim, Pawlotsky, Jean‐Michel, Sarrazin, Christoph, Weis, Nina, Schønning, Kristian, Krarup, Henrik, Bukh, Jens, Gottwein, Judith Margarete

Volltext

Detection of Hepatitis C Virus Infection from Patient Sera in Cell Culture Using Semi-Automated Image Analysis von Schäfer, Noemi, Rothhaar, Paul, Heuss, Christian, Neumann-Haefelin, Christoph, Thimme, Robert, Dietz, Julia, Sarrazin, Christoph, Schnitzler, Paul, Merle, Uta, Pérez-del-Pulgar, Sofía, Laketa, Vibor, Lohmann, Volker

Volltext

Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin von Berg, Thomas, von Wagner, Michael, Nasser, Samer, Sarrazin, Christoph, Heintges, Tobias, Gerlach, Tilman, Buggisch, Peter, Goeser, Tobias, Rasenack, Jens, Pape, Gerd R., Schmidt, Wolfgang E., Kallinowski, Birgit, Klinker, Hartwig, Spengler, Ulrich, Martus, Peter, Alshuth, Ulrich, Zeuzem, Stefan

Volltext